# A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With Metformin

> **NCT00231660** · PHASE3 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 211 (actual)

## Conditions studied

- Obesity
- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Adult-Onset

## Interventions

- **DRUG:** topiramate

## Key facts

- **NCT ID:** NCT00231660
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10
- **Primary completion:** —
- **Final completion:** 2002-06
- **Target enrollment:** 211 (ACTUAL)
- **Last updated:** 2011-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00231660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00231660, "A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With Metformin". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00231660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*